InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Large Decrease in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 1,710,000 shares, a decline of 43.9% from the February 28th total of 3,046,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Stock Performance

OTCMKTS INCPF remained flat at $3.26 on Friday. The company’s fifty day simple moving average is $3.26 and its 200-day simple moving average is $3.26. InnoCare Pharma has a 12 month low of $3.26 and a 12 month high of $3.72.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.